Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 1-7 , October 2010

The clinical use of the 10g monofilament and its limitations: A review

Received 8 February 2010 ,Revised 15 June 2010 ,Accepted 17 June 2010.

References 

  1. International Federation of Diabetes (IDF). Diabetes Atlas. 3rd ed. [http://www.eatlas.idf.org/index.asp?menu_id=200831811288].
  2. Ministry of Health Singapore. Details of National Health Survey; 2004 Findings. [http://www.moh.gov.sg/mohcorp/uploadedfiles/News/Current_Issues/2005/Apr/Details_of_NHS_04_findings.pdf].
  3. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology. 1993;43(4):817–824
  4. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(22):150–154
  5. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. & the EURODIAB IDDM Complications Study Group Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377–1384
  6. Tesfaye S. Epidemiology and etiology of diabetic peripheral neuropathies. Adv Stud Med. 2004;4(10 G):S1014–S1021
  7. Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of ulcers and predictive risk factors. Diab Care. 1998;21(7):1071–1075
  8. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158(2):157–162
  9. McGill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care? An objective analysis. Intern Med J. 2005;35(8):451–456
  10. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diab Care. 1999;22(1):157–162
  11. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diab Care. 1994;17(6):557–560
  12. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diab Care. 1999;22(7):1029–1035
  13. Nather A, Bee CS, Huak CY, Chew JLL, Lin CB, Neo S, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabet Complications. 2008;22(2):77–82
  14. Ministry of Health Singapore. Clinical practice guidelines: diabetes mellitus. Singapore: Ministry of Health; 2006. [http://www.moh.gov.sg/mohcorp/uploadedFiles/Publications/Guidelines/Clinical_Practice_Guidelines/Diabetes%20Mellitus.pdf].
  15. Mayfield JA, Sugarman JR. The use of the Semmes–Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract. 2000;49(S11):S17–S29
  16. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. J Am Med Assoc. 2005;293(2):217–228
  17. Jones ER, Childers RL. Contemporary college physics. 3rd ed.. New York: McGraw-Hill; 2001;p.279
  18. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes–Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diab Res Clin Prac. 1991;13(1–2):63–67
  19. McNeely MJ, Boyko EJ, Ahroni JH, Stensel VL, Reiber GE, Smith DG, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?. Diab Care. 1995;18(2):216–219
  20. Olmos PR, Cataland S, O’Dorisio TM, Casey CA, Smead WL, Simon SR. The Semmes–Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci. 1995;309(2):76–82
  21. Vileikyte L, Hutchings G, Hollis S, Boulton AJM. The tactile circumferential discriminator: a new, simple screening device to identify diabetic patients at risk of foot ulceration. Diab Care. 1997;20(4):623–626
  22. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158(3):289–292
  23. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diab Care. 1998;21(10):1714–1719
  24. Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diab Care. 1992;15(10):1386–1389
  25. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diab Care. 1997;20(8):1273–1278
  26. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diab Care. 1999;22(7):1036–1042
  27. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial. Diab Care. 2000;23(5):606–611
  28. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The north-west diabetes foot care study: incidence of, and risk factors for new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–384
  29. Carrington AL, Shaw JE, Van Schie CHM, Abbott CA, Vileikyte L, Boulton AJM. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?. Diab Care. 2002;25(11):2010–2015
  30. Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle diabetic foot study. Diab Care. 2006;29(6):1202–1207
  31. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet Med. 1998;15(1):80–84
  32. Smieja M, Hunt DL, Edelman D, Etchells E, Cornuz J, Simel DL for the International Cooperative Group for Clinical Examination Research. Clinical examination for the detection of protective sensation in the feet of diabetic patients. J Gen Intern Med. 1999;14(7):418–424
  33. Birke JA, Rolfson RJ. Evaluation of a self administered sensory testing tool to identify patients at risk of diabetes related foot problems. Diab Care. 1997;21:23–25
  34. Gerr FE, Letz R. Reliability of a widely used test of peripheral cutaneous vibration sensitivity and a comparison of two testing protocols. Br J Ind Med. 1988;45(9):635–639
  35. Miranda-Palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJ. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diab Res Clin Pract. 2005;70(1):8–12
  36. Paisley AN, Abbott CA, Van Schie CHM, Boulton AJM. A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabet Med. 2002;19(5):400–405
  37. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes–Weinstein monofilament. Diab Care. 1999;22(4):598–602
  38. Lee S, Kim H, Choi S, Park Y, Kim Y, Cho B. Clinical usefulness of the two-site Semmes–Weinstein monofilament test for detecting diabetic peripheral neuropathy. J Korean Med Sci. 2003;18(1):103–107
  39. Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, et al. Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabet Complicat. 2005;19(1):47–53
  40. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diab Care. 2001;24(2):250–256
  41. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diab Res Clin Pract. 2001;54(2):115–128
  42. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diab Care. 1990;13(10):1057–1061
  43. Nagai Y, Sugiyama Y, Abe T, Nomura G. 4-g monofilament is clinically useful for detecting diabetic peripheral neuropathy. Diab Care. 2001;24(1):183–184
  44. Saltzman CL, Rashid R, Hayes A, Fellner C, Fitzpatrick D, Klapach A, et al. 4.5-Gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. J Bone Joint Surg. 2004;86A(4):717–723
  45. Jeng C, Michelson J, Mizel M. Sensory thresholds of normal human feet. Foot Ankle Int. 2000;21(6):501–514
  46. Thomson MP, Potter J, Finch PM, Paisey RB. Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with type 2 diabetes mellitus. J Foot Ankle Res. 2008;1(9):
  47. Yong R, Karas TJ, Smith KD, Petrov O. The durability of the Semmes–Weinstein 5.07 monofilament. J Foot Ankle Surg. 2000;39(1):34–38
  48. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diab Care. 2000;23(7):984–988
  49. Spruce M. Investigation into the role of human bias in 10g monofilament force delivery. In: Paper presented at the annual conference of the society of chiropodists and podiatrists, 23rd October, Bournemouth, UK; 2008.
  50. McGill M, Molyneaux L, Yue DK. Use of the Semmes–Weinstein 5.07/10 gram monofilament: the long and the short of it. Diabet Med. 1998;15(7):615–617
  51. Bove G. Mechanical sensory threshold testing using nylon monofilaments: the pain field's “Tin Standard”. Pain. 2006;124(1–2):13–17
  52. National Institute for Clinical Excellence (NICE). Type 2 diabetes. Prevention and management of foot problems; 2004. Available from http://www.nice.org.uk/nicemedia/pdf/CG010NICEguideline.pdf.
  53. Mason J, O’Keeffe C, McIntosh A, Hutchinson A, Booth A, Young RJ. A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I. Prevention. Diabet Med. 1999;16(10):799–800
  54. Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. A systematic review. Endocrinol Metab Clin North Am. 2002;31(3):633–658
  55. Shin JB, Seong YJ, Lee HJ, Kim SH, Park JR. Foot screening technique in a diabetic population. J Korean Med Sci. 2000;15(1):78–82

PII: S0168-8227(10)00323-2

doi: 10.1016/j.diabres.2010.06.021

Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 1-7 , October 2010

Article Tools